About Us

MST™: Reimagining the potential of
skin care medicine

With Molecule Stabilizing Technology (MST™), Foamix is working on developing new
dermatological treatments to be applied in ways that were once thought impossible


Our signature technological platform is our proprietary Molecule Stabilizing Technology (MST™). This innovation may allow for localized delivery of therapeutic agents that previously were not stable in topical formulations.

Foamix has developed a new foam technology designed without surfactants (surface-active agents that reduce the surface tension of oil or solid-water interfaces, commonly referred to as wetting agents, dispersing agents, and emulsifiers).1 Our formulation uses natural oils that work with the natural moisturizing oils of human skin. By leveraging foam, a prominent topical delivery system that can be engineered, refined, and elevated, Foamix is taking advantage of an innovative and easy-to-apply alternative to creams and ointments.

The potential advantages of MST™:

  • Unique hydrophobic foam helps medicine be easily applied and absorbed by the skin
  • Proprietary delivery system has the potential to stabilize hard-to-deliver medicines for topical application
  • Free of primary irritants

The promise of MST™ is fueling our pipeline

MST™ has already made one product possible and is playing a role in our other investigational new drug candidates.


The safety and efficacy of these products has not been established. There is no guarantee that these products will receive health authority approval or become commercially available.

  1. Millodot: Dictionary of Optometry and Visual Science, 7th edition. © 2009 Butterworth-Heinemann